These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 7903783

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Gabapentin: a new agent for the management of epilepsy.
    Andrews CO, Fischer JH.
    Ann Pharmacother; 1994 Oct; 28(10):1188-96. PubMed ID: 7841578
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Treatment of seizures in acute intermittent porphyria: safety and efficacy of gabapentin.
    Zadra M, Grandi R, Erli LC, Mirabile D, Brambilla A.
    Seizure; 1998 Oct; 7(5):415-6. PubMed ID: 9808120
    [Abstract] [Full Text] [Related]

  • 46. [Refractory epilepsy in adults and the new antiepileptic drugs: the role of gabapentin].
    Galdames D, Aguilera L, Fauré E.
    Rev Med Chil; 1995 Apr; 123(4):500-8. PubMed ID: 8525196
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Movement disorders associated with the use of gabapentin.
    Reeves AL, So EL, Sharbrough FW, Krahn LE.
    Epilepsia; 1996 Oct; 37(10):988-90. PubMed ID: 8822698
    [Abstract] [Full Text] [Related]

  • 49. Choreoathetotic movements: A possible side effect of gabapentin.
    Buetefisch CM, Gutierrez A, Gutmann L.
    Neurology; 1996 Mar; 46(3):851-2. PubMed ID: 8618709
    [No Abstract] [Full Text] [Related]

  • 50. Gabapentin: a unique anti-epileptic agent.
    Dougherty JA, Rhoney DH.
    Neurol Res; 2001 Dec; 23(8):821-9. PubMed ID: 11760873
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Background and rationale for use of anticonvulsants in psychiatry.
    Sussman N.
    Cleve Clin J Med; 1998 Dec; 65 Suppl 1():SI7-14; discussion SI45-7. PubMed ID: 12033206
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Gabapentin dosing in the treatment of epilepsy.
    McLean MJ, Gidal BE.
    Clin Ther; 2003 May; 25(5):1382-406. PubMed ID: 12867216
    [Abstract] [Full Text] [Related]

  • 55. New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin.
    Devinsky O, Vazquez B, Luciano D.
    J Child Neurol; 1994 Oct; 9 Suppl 1():S33-45. PubMed ID: 7822751
    [Abstract] [Full Text] [Related]

  • 56. Use of gabapentin to reduce chronic neuropathic pain in Fabry disease.
    Ries M, Mengel E, Kutschke G, Kim KS, Birklein F, Krummenauer F, Beck M.
    J Inherit Metab Dis; 2003 Oct; 26(4):413-4. PubMed ID: 12971431
    [Abstract] [Full Text] [Related]

  • 57. Fortnightly review: drug treatment of epilepsy.
    Feely M.
    BMJ; 1999 Jan 09; 318(7176):106-9. PubMed ID: 9880286
    [No Abstract] [Full Text] [Related]

  • 58. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study.
    Appleton R, Fichtner K, LaMoreaux L, Alexander J, Maton S, Murray G, Garofalo E.
    Dev Med Child Neurol; 2001 Apr 09; 43(4):269-73. PubMed ID: 11305405
    [Abstract] [Full Text] [Related]

  • 59. If comparisons can be odious, so can assumptions.
    Jackson D, Duthie T.
    Seizure; 1996 Sep 09; 5(3):247-8. PubMed ID: 8902930
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.